Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Cancer Res. 2019 Jan 4;79(7):1612–1623. doi: 10.1158/0008-5472.CAN-18-2705

Table 1.

Precursor B cell lymphomas develop in the Smarcal1- and Zranb3-deficient Eμ-myc cohorts

Smarcal1 Zranb3
Phenotype +/+ +/ Δ Δ/Δ +/+ +/− −/−
B220+ CD19+ IgM+/− IgD+/− 9 (100%) 9 (81.8%) 9 (100%) 8 (100%) 9 (75.0%) 6 (85.7%)
B220+ CD19+/− IgMlo
Sca1+/lo CD34+ CD4+
0 (0%) 2 (18.2%) 0 (0%) 0 (0%) 3 (25.0%) 1 (14.3%)